|
|
Article: New hypersensitivity therapy research from University of Western Ontario discussed.
- Article from:
- Biotech Week
- Article date:
- July 8, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
New investigation results, 'Patch testing for the diagnosis of anticonvulsant hypersensitivity syndrome: a systematic review,' are detailed in a study published in Drug Safety. According to a study from London, Canada, "Anticonvulsant hypersensitivity syndrome (AHS), also known by the other names drug rash (reaction) with eosinophilia and systemic symptoms (DRESS) and drug-induced hypersensitivity syndrome (DIHS), is a rare and potentially fatal reaction that occurs in susceptible patients after exposure to certain drugs, including aromatic anticonvulsants. Because of its ill-defined clinical picture and resemblance to other diseases, the diagnosis of AHS is often ...